Candidate registration
Employer registration
Candidate registration
Employer registration
Login
Forgot password
Forgot password
Sign in
Candidate registration
Sign in
Candidate registration
Sign in
Employer registration
  Home  |   |  Job Seeker Register  |  Employer Register    You're not logged in! Get Job Alerts | Subscribe to RSS Feed
 Follow us on  
Translate:
Sign in
Candidate registration
Company Profile:

Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. In the U.S., Cubist markets CUBICIN® (daptomycin for injection), the first antibiotic in a class of anti-infectives called lipopeptides.   Cubist also has an agreement with Optimer Pharmaceuticals, Inc. to co-promote Optimer's drug, DIFICID™ (fidaxomicin), in the U.S. as a treatment of Clostridium difficile-associated diarrhea (CDAD).  The Cubist clinical product pipeline currently consists of a Phase 3 program focused on the development of a novel cephalosporin to address certain serious infections caused by multi-drug resistant (MDR) Gram-negative organisms and a Phase 2 program for the treatment of CDAD. Cubist also is working on several pre-clinical programs being developed to address areas of significant medical needs. These include therapies to treat various serious bacterial infections and agents to treat acute pain.


Headquartered in Lexington, Massachusetts, Cubist employs more than 600 people — approximately 380 in Massachusetts. The company's total net revenues increased 13% to $636.4 million in 2010 from $562.1 million in 2009.  At Cubist, we believe our core strength is the broad range of individuals who make up our team. The variety of innovative ideas, knowledge, experiences, and cultures our employees bring to their work give us our greatest competitive advantage.

Cubist is dedicated to Diversity Inclusion, Diversity Hiring and Diversity Jobs.


no jobs found

CUBIST News

Biotech Equities Roundup -- Keryx Biopharma, Vertex Pharma, NPS Pharma, Cubist Pharma, and Idera Pharma
2014-01-06 08:50
Biotech Equities Roundup -- Keryx Biopharma, Vertex Pharma, NPS Pharma, Cubist Pharma, and Idera Pharma
2014-01-06 08:50
Financial Results, Clinical Trial Initiations, Drug Designations, Appointments, and Study Results - Research Reports on Cubist, Jazz, InterMune, NPS Pharmaceuticals and ACADIA
2014-01-30 09:00
Financial Results, Clinical Trial Initiations, Drug Designations, Appointments, and Study Results - Research Reports on Cubist, Jazz, InterMune, NPS Pharmaceuticals and ACADIA
2014-01-30 09:00

                                       PharmaDiversity is a charter member of International Association of Employment Web Sites        PharmaDiversity Job Board selected Top 100 Job Boards 2009         PharmaDiversity Weddles award & honor           PharmaDiversity Job Board Advertise with us information logo   Follow us on  

Copyright © 2006-2013 PharmaDiversityJobBoard.com

Popular locations: GA | CA | NY | NJ | MI | TX | WA | NC | FL | MA | IL | TN | VA | IN | Louisiana

Popular categories: Pharmaceutical Sales | Pharmaceuticals | Management | Business Development | Executive | Biotech | Pharmaceutical Jobs | Clinical Development | Clinical Research | Project Management | Research and Development | Sales | Human Resources | Mechanic | Medical Advisor

Home    About us    Job search    Employer area    Contact us    Terms & conditions    Privacy policy